Rejuvenate Bio Company
Rejuvenate Bio has developed a cardio-protective gene therapy that holds the promise of stopping the progression of MVD. We are preparing to run a pilot study in dogs with MVD.
Technology:
Others
Industry:
Gene therapy, PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2017
Employees Number:
51-100
Funding Status:
Seed
Investors Number:
3
Total Funding:
17.1M
Last Funding Date:
Apr 27, 2021
Last Funding Type:
Venture
Register and Claim Ownership